Brett Sandercock - 16 Nov 2021 Form 4 Insider Report for RESMED INC (RMD)

Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
16 Nov 2021
Transactions value $
$5,187,932
Form type
4
Filing time
18 Nov 2021, 16:41:58 UTC
Previous filing
12 Nov 2021
Next filing
14 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $5.19M +20.4K +24% $254.81 105K 16 Nov 2021 Direct F1
transaction RMD ResMed Common Stock Award $0 +1.16K +1.1% $0.00 106K 18 Nov 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met.
F2 Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.